GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sedana Medical AB (OSTO:SEDANA) » Definitions » Research & Development

Sedana Medical AB (OSTO:SEDANA) Research & Development : kr21.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sedana Medical AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Sedana Medical AB's Research & Development for the three months ended in Mar. 2024 was kr5.3 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was kr21.0 Mil.

Sedana Medical AB Research & Development Historical Data

The historical data trend for Sedana Medical AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sedana Medical AB Research & Development Chart

Sedana Medical AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only 7.35 7.86 19.70 19.94 20.81

Sedana Medical AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.10 4.97 5.07 5.68 5.27

Sedana Medical AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr21.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sedana Medical AB  (OSTO:SEDANA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sedana Medical AB Research & Development Related Terms

Thank you for viewing the detailed overview of Sedana Medical AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Sedana Medical AB (OSTO:SEDANA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sedana Medical AB (OSTO:SEDANA) » Definitions » Research & Development
Comparable Companies
OSTO:BICO OSTO:BACTI B OSTO:CRAD B OSTO:BRAIN OSTO:MNTC OSTO:SEZI OSTO:INTEG B OSTO:PRO OSTO:CEVI OSTO:STIL ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
7D2A:Germany
Address
Vendevagen 89, Danderyd, SWE, SE-182 32
Website
https://www.sedanamedical.com
Sedana Medical AB is a Sweden-based medical technology company. It's Anaesthetic Conserving Device (AnaConDa) is an anaesthetic delivery system developed for the administration of volatile anaesthetics such as isoflurane or sevoflurane to invasively ventilated patients. AnaConDa is a small device that is inserted in the breathing circuit between the ET-Tube and the Y-piece. The product range of the group is AnaConDa, AnaConDa-S, AnaConDa syringe, FlurAbsorb-S, FlurAbsorb accessory kit, Nafion line, and others. The company operates in Sweden, Germany, Spain, Ireland, and France, out of which Germany accounts for the majority of the revenue.

Sedana Medical AB (OSTO:SEDANA) Headlines

No Headlines